Jan 262017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– UK, London – Advanced Oncotherapy PLC (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the appointment of Professor Steve Myers OBE and Mr Hans von Celsing as Non-Executive Directors with immediate effect.… => Read more

Advanced Oncotherapy appoints Pr Steve Myers and Hans von Celsing to its Board as Non-Executive Directors

From:: Advanced Oncotherapy appoints Pr Steve Myers and Hans von Celsing to its Board as Non-Executive Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: